New analysis from the EARLY TAVR trial showed patients between the age of 65 and 70 years old derived the most benefits of a ...

Not surprisingly, older patients fared worse, but some older and younger patients saw stroke benefits requiring more study.

Edwards Lifesciences (NYSE:EW) recently celebrated the FDA approval of its SAPIEN 3 TAVR therapy for asymptomatic aortic stenosis patients, a significant development in cardiac care. This milestone, ...

A trend toward higher mortality in women with PPM who received a self-expanding valves deserves more scrutiny, though.

Munich news, health insurance, technology, jobs and other topics for expatriates. The Eye Newspapers covers daily news and offers services for foreigners.

For patients with asymptomatic or symptomatic carotid stenosis of 50 percent or greater with a low or intermediate predicted ...

The Driver and Vehicle Licensing Agency requires motorists to declare any medical conditions which could impact their driving ...

Verve Therapeutics, a clinical-stage company developing a new class of genetic medicines for cardiovascular disease, today ...